Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.171NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.57NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.67ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.67NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.279ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.279ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.279ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.279NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.67ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-18330.5China
B.1.1.67NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AD.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.201ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.201ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.201NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
W.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
W.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
W.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used